Novartis AG (SWX:NOVNEE)

Market Cap	201.60B
Revenue (ttm)	43.89B
Net Income (ttm)	10.86B
Shares Out	n/a
EPS (ttm)	5.45
PE Ratio	18.57
Forward PE	14.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	182,200
Average Volume	180,000
Open	103.68
Previous Close	103.88
Day's Range	103.58 - 104.70
52-Week Range	81.55 - 106.90
Beta	0.49
RSI	56.43
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVNEE

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD